Cortisol: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
Line 5: Line 5:
|drugClass=anti-inflammatory agent
|drugClass=anti-inflammatory agent
|indicationType=treatment
|indicationType=treatment
|indication=itching associated with minor skin irritations and rashes due to eczema, insect bites, soaps and detergents, cosmetics, jewelry, seborrheic dermatitis, psoriasis, poison ivy, oak or sumac and for external genital, feminine and anal itching
|indication=itching associated with minor skin irritations and rashes due to [[eczema]], insect bites, soaps and detergents, cosmetics, jewelry, [[seborrheic dermatitis]], [[psoriasis]], poison ivy, oak or sumac and for external genital, feminine and anal itching
|blackBoxWarningTitle=Title
|blackBoxWarningTitle=Title
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
|blackBoxWarningBody=<i><span style="color:#FF0000;">ConditionName: </span></i>
Line 117: Line 117:
|warnings=Warnings:
|warnings=Warnings:


For external use only
*For external use only


Do not use
*Do not use


    in children under 2 years of age  
:*in children under 2 years of age  
    if you have a vaginal discharge  
:*if you have a vaginal discharge  
    for the treatment of diaper rash  
:*for the treatment of diaper rash  


Ask a doctor before use if you have
*Ask a doctor before use if you have


    external genital or feminine itching  
:*external genital or feminine itching
    external anal itching  
:*external anal itching
    bleeding  
:*bleeding  


When using this product
*When using this product


    avoid contact with eyes  
:*avoid contact with eyes  
    do not exceed the recommended daily dosage unless directed by a doctor  
:*do not exceed the recommended daily dosage unless directed by a doctor  
    do not put this product into the rectum by using fingers or any mechanical device or applicator  
:*do not put this product into the rectum by using fingers or any mechanical device or applicator  


Stop use and ask a doctor
*Stop use and ask a doctor


    if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, stop use and do not begin use of any other hydrocortisone product  
:*if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, stop use and do not begin use of any other hydrocortisone product  


====Keep out of reach of children====
====Keep out of reach of children====


If swallowed, get medical help or contact a Poison Control Center right away.
*If swallowed, get medical help or contact a Poison Control Center right away.
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.
|clinicalTrials=There is limited information regarding <i>Clinical Trial Experience</i> of {{PAGENAME}} in the drug label.


=====Body as a Whole=====








=====Cardiovascular=====
|postmarketing=*There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.


=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====
=====Respiratory=====
=====Skin and Hypersensitivy Reactions=====
=====Special Senses=====
=====Urogenital=====
=====Miscellaneous=====
<!--Postmarketing Experience-->
|postmarketing=There is limited information regarding <i>Postmarketing Experience</i> of {{PAGENAME}} in the drug label.
=====Body as a Whole=====
=====Cardiovascular=====
=====Digestive=====
=====Endocrine=====
=====Hematologic and Lymphatic=====
=====Metabolic and Nutritional=====
=====Musculoskeletal=====
=====Neurologic=====
=====Respiratory=====
=====Skin and Hypersensitivy Reactions=====
=====Special Senses=====
=====Urogenital=====
=====Miscellaneous=====




Line 274: Line 164:


There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of {{PAGENAME}} in women who are pregnant.
|useInLaborDelivery=There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInLaborDelivery=*There is no FDA guidance on use of {{PAGENAME}} during labor and delivery.
|useInNursing=There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInNursing=*There is no FDA guidance on the use of {{PAGENAME}} with respect to nursing mothers.
|useInPed=There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInPed=*There is no FDA guidance on the use of {{PAGENAME}} with respect to pediatric patients.
|useInGeri=There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGeri=*There is no FDA guidance on the use of {{PAGENAME}} with respect to geriatric patients.
|useInGender=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInGender=*There is no FDA guidance on the use of {{PAGENAME}} with respect to specific gender populations.
|useInRace=There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRace=*There is no FDA guidance on the use of {{PAGENAME}} with respect to specific racial populations.
|useInRenalImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInRenalImpair=*There is no FDA guidance on the use of {{PAGENAME}} in patients with renal impairment.
|useInHepaticImpair=There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInHepaticImpair=*There is no FDA guidance on the use of {{PAGENAME}} in patients with hepatic impairment.
|useInReproPotential=There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInReproPotential=*There is no FDA guidance on the use of {{PAGENAME}} in women of reproductive potentials and males.
|useInImmunocomp=There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.
|useInImmunocomp=*There is no FDA guidance one the use of {{PAGENAME}} in patients who are immunocompromised.


<!--Administration and Monitoring-->
<!--Administration and Monitoring-->
|administration=Directions:
|administration=Directions:


For minor skin irritations and rashes,
*For minor skin irritations and rashes,


    adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily.  
:*adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily.  


For external anal itching:
*For external anal itching:


    adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly  
:*adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly  
    gently dry by patting or blotting with toilet tissue or soft cloth before application of this product  
:*gently dry by patting or blotting with toilet tissue or soft cloth before application of this product  
    children : under 12 years of age, consult a doctor.  
:*children : under 12 years of age, consult a doctor.  


Other information:
*Other information:


    do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal  
:*do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal  
    store at room temperature  
:*store at room temperature  
    see crimp of tube for Lot Number and Expiration Date
:*see crimp of tube for Lot Number and Expiration Date
|monitoring=There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.
|monitoring=*There is limited information regarding <i>Monitoring</i> of {{PAGENAME}} in the drug label.


* Description
* Description


<!--IV Compatibility-->
<!--IV Compatibility-->
|IVCompat=There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.
|IVCompat=*There is limited information regarding <i>IV Compatibility</i> of {{PAGENAME}} in the drug label.


<!--Overdosage-->
<!--Overdosage-->
|overdose====Acute Overdose===
|overdose
 
====Signs and Symptoms====
 
* Description
 
====Management====
 
* Description
 
===Chronic Overdose===


There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
There is limited information regarding <i>Chronic Overdose</i> of {{PAGENAME}} in the drug label.
Line 338: Line 218:


<!--Pharmacodynamics-->
<!--Pharmacodynamics-->
|PD=There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.
|PD=*There is limited information regarding <i>Pharmacodynamics</i> of {{PAGENAME}} in the drug label.


<!--Pharmacokinetics-->
<!--Pharmacokinetics-->
|PK=There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.
|PK=*There is limited information regarding <i>Pharmacokinetics</i> of {{PAGENAME}} in the drug label.


<!--Nonclinical Toxicology-->
<!--Nonclinical Toxicology-->
|nonClinToxic=There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.
|nonClinToxic=*There is limited information regarding <i>Nonclinical Toxicology</i> of {{PAGENAME}} in the drug label.


<!--Clinical Studies-->
<!--Clinical Studies-->
|clinicalStudies=There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.
|clinicalStudies=*There is limited information regarding <i>Clinical Studies</i> of {{PAGENAME}} in the drug label.


<!--How Supplied-->
<!--How Supplied-->
Line 361: Line 241:
[[File:Hydrocortisone label.png|600px|thumbnail|left]]
[[File:Hydrocortisone label.png|600px|thumbnail|left]]
{{clear}}
{{clear}}
|fdaPatientInfo=There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.
|fdaPatientInfo=*There is limited information regarding <i>Patient Counseling Information</i> of {{PAGENAME}} in the drug label.


<!--Precautions with Alcohol-->
<!--Precautions with Alcohol-->

Revision as of 15:40, 8 October 2014

Cortisol
Adult Indications & Dosage
Pediatric Indications & Dosage
Contraindications
Warnings & Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Administration & Monitoring
Overdosage
Pharmacology
Clinical Studies
How Supplied
Images
Patient Counseling Information
Precautions with Alcohol
Brand Names
Look-Alike Names

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Deepika Beereddy, MBBS [2]

Disclaimer

WikiDoc MAKES NO GUARANTEE OF VALIDITY. WikiDoc is not a professional health care provider, nor is it a suitable replacement for a licensed healthcare provider. WikiDoc is intended to be an educational tool, not a tool for any form of healthcare delivery. The educational content on WikiDoc drug pages is based upon the FDA package insert, National Library of Medicine content and practice guidelines / consensus statements. WikiDoc does not promote the administration of any medication or device that is not consistent with its labeling. Please read our full disclaimer here.

Overview

Cortisol is a anti-inflammatory agent that is FDA approved for the treatment of itching associated with minor skin irritations and rashes due to eczema, insect bites, soaps and detergents, cosmetics, jewelry, seborrheic dermatitis, psoriasis, poison ivy, oak or sumac and for external genital, feminine and anal itching. Common adverse reactions include {{{adverseReactions}}}.

Adult Indications and Dosage

FDA-Labeled Indications and Dosage (Adult)

Condition1
  • Dosing Information
  • Dosage
Condition2
  • Dosing Information
  • Dosage
Condition3
  • Dosing Information
  • Dosage
Condition4
  • Dosing Information
  • Dosage

Off-Label Use and Dosage (Adult)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Cortisol in adult patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Cortisol in adult patients.

Pediatric Indications and Dosage

FDA-Labeled Indications and Dosage (Pediatric)

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding FDA-Labeled Use of Cortisol in pediatric patients.

Off-Label Use and Dosage (Pediatric)

Guideline-Supported Use

Condition1
  • Developed by:
  • Class of Recommendation:
  • Strength of Evidence:
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Guideline-Supported Use of Cortisol in pediatric patients.

Non–Guideline-Supported Use

Condition1
  • Dosing Information
  • Dosage
Condition2

There is limited information regarding Off-Label Non–Guideline-Supported Use of Cortisol in pediatric patients.

Contraindications

  • Condition1

Warnings

Warnings:

  • For external use only
  • Do not use
  • in children under 2 years of age
  • if you have a vaginal discharge
  • for the treatment of diaper rash
  • Ask a doctor before use if you have
  • external genital or feminine itching
  • external anal itching
  • bleeding
  • When using this product
  • avoid contact with eyes
  • do not exceed the recommended daily dosage unless directed by a doctor
  • do not put this product into the rectum by using fingers or any mechanical device or applicator
  • Stop use and ask a doctor
  • if condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, stop use and do not begin use of any other hydrocortisone product

Keep out of reach of children

  • If swallowed, get medical help or contact a Poison Control Center right away.

Adverse Reactions

Clinical Trials Experience

There is limited information regarding Clinical Trial Experience of Cortisol in the drug label.

Postmarketing Experience

  • There is limited information regarding Postmarketing Experience of Cortisol in the drug label.

Drug Interactions

  • Drug
  • Description

Use in Specific Populations

Pregnancy

Pregnancy Category (FDA):

  • Pregnancy Category


Pregnancy Category (AUS):

  • Australian Drug Evaluation Committee (ADEC) Pregnancy Category

There is no Australian Drug Evaluation Committee (ADEC) guidance on usage of Cortisol in women who are pregnant.

Labor and Delivery

  • There is no FDA guidance on use of Cortisol during labor and delivery.

Nursing Mothers

  • There is no FDA guidance on the use of Cortisol with respect to nursing mothers.

Pediatric Use

  • There is no FDA guidance on the use of Cortisol with respect to pediatric patients.

Geriatic Use

  • There is no FDA guidance on the use of Cortisol with respect to geriatric patients.

Gender

  • There is no FDA guidance on the use of Cortisol with respect to specific gender populations.

Race

  • There is no FDA guidance on the use of Cortisol with respect to specific racial populations.

Renal Impairment

  • There is no FDA guidance on the use of Cortisol in patients with renal impairment.

Hepatic Impairment

  • There is no FDA guidance on the use of Cortisol in patients with hepatic impairment.

Females of Reproductive Potential and Males

  • There is no FDA guidance on the use of Cortisol in women of reproductive potentials and males.

Immunocompromised Patients

  • There is no FDA guidance one the use of Cortisol in patients who are immunocompromised.

Administration and Monitoring

Administration

Directions:

  • For minor skin irritations and rashes,
  • adults and children 2 years of age and older: apply to affected area not more than 3 to 4 times daily.
  • For external anal itching:
  • adults: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly
  • gently dry by patting or blotting with toilet tissue or soft cloth before application of this product
  • children : under 12 years of age, consult a doctor.
  • Other information:
  • do not use if seal is punctured or is not visible. To open, reverse cap to puncture seal
  • store at room temperature
  • see crimp of tube for Lot Number and Expiration Date

Monitoring

  • There is limited information regarding Monitoring of Cortisol in the drug label.
  • Description

IV Compatibility

  • There is limited information regarding IV Compatibility of Cortisol in the drug label.

Overdosage

There is limited information regarding Cortisol overdosage. If you suspect drug poisoning or overdose, please contact the National Poison Help hotline (1-800-222-1222) immediately.

Pharmacology

Mechanism of Action

Structure

File:Cortisol01.png
This image is provided by the National Library of Medicine.

Pharmacodynamics

  • There is limited information regarding Pharmacodynamics of Cortisol in the drug label.

Pharmacokinetics

  • There is limited information regarding Pharmacokinetics of Cortisol in the drug label.

Nonclinical Toxicology

  • There is limited information regarding Nonclinical Toxicology of Cortisol in the drug label.

Clinical Studies

  • There is limited information regarding Clinical Studies of Cortisol in the drug label.

How Supplied

Storage

There is limited information regarding Cortisol Storage in the drug label.

Images

Drug Images

{{#ask: Page Name::Cortisol |?Pill Name |?Drug Name |?Pill Ingred |?Pill Imprint |?Pill Dosage |?Pill Color |?Pill Shape |?Pill Size (mm) |?Pill Scoring |?NDC |?Drug Author |format=template |template=DrugPageImages |mainlabel=- |sort=Pill Name }}

Package and Label Display Panel

{{#ask: Label Page::Cortisol |?Label Name |format=template |template=DrugLabelImages |mainlabel=- |sort=Label Page }}

Patient Counseling Information

  • There is limited information regarding Patient Counseling Information of Cortisol in the drug label.

Precautions with Alcohol

  • Alcohol-Cortisol interaction has not been established. Talk to your doctor about the effects of taking alcohol with this medication.

Brand Names

Look-Alike Drug Names

Drug Shortage Status

Price

References

The contents of this FDA label are provided by the National Library of Medicine.

  1. ↑ Empty citation (help)
  2. ↑ "http://www.ismp.org". External link in |title= (help)

{{#subobject: 

 |Page Name=Cortisol
 |Pill Name=No image.jpg
 |Drug Name=
 |Pill Ingred=|+sep=;
 |Pill Imprint=
 |Pill Dosage={{{dosageValue}}} {{{dosageUnit}}}
 |Pill Color=|+sep=;
 |Pill Shape=
 |Pill Size (mm)=
 |Pill Scoring=
 |Pill Image=
 |Drug Author=
 |NDC=

}}

{{#subobject: 

 |Label Page=Cortisol
 |Label Name=Cortisol11.png

}}

{{#subobject: 

 |Label Page=Cortisol
 |Label Name=Cortisol11.png

}}

Retrieved from "https://www.wikidoc.org/index.php?title=Cortisol&oldid=1030901"